Buffalo News: Collins re-elected to board of biotech firm at center of ethics probe
Rep. Chris Collins won re-election Wednesday – to the board of directors of the struggling Australian biotech firm he invested in at a discount and touted to his colleagues, prompting a House Ethics Committee investigation.
"He should not be doing it – absolutely not," said Meredith McGehee, strategic adviser for the Campaign Legal Center and a longtime good-government advocate. "If he wants to do this, he shouldn't be in Congress. What master is he serving?"
McGehee said Collins should make a choice – that either he should serve as a member of Congress or on the board of directors of the Australian biotech firm.